Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 30;27(3):408-418.
doi: 10.5056/jnm20105.

Predictors of Early Readmissions in Hospitalized Patients With Gastroparesis: A Nationwide Analysis

Affiliations

Predictors of Early Readmissions in Hospitalized Patients With Gastroparesis: A Nationwide Analysis

Ravi B Pavurala et al. J Neurogastroenterol Motil. .

Abstract

Background/aims: Gastroparesis is a chronic gastrointestinal disorder that frequently presents with symptoms that are difficult to manage, necessitating frequent hospitalizations. We sought to determine the predictors of early readmission due to gastroparesis based on etiology.

Methods: We identified all adults discharged with a principal diagnosis of gastroparesis after hospitalization from the 2014 Nationwide Readmission Database. We compared etiology wise (diabetes, post-surgical, and idiopathic) early readmission. Multivariate regression analyses were performed to identify significant predictors of 30-day readmission.

Results: A total of 12 689 patients were identified, 30.7% diabetic, 2.6% post-surgical, and 66.7% were idiopathic. Patients with diabetic gastroparesis were more likely to be readmitted within 30 days than idiopathic (adjusted odds ratio [aOR], 0.81; 95% confidence interval [CI], 0.69-0.94) and post-surgical gastroparesis (aOR, 0.58; 95% CI, 0.34-0.98). Pyloroplasty was associated with less likelihood of 30-day readmission (aOR, 0.45; 95% CI, 0.20-0.97). In addition, male gender (aOR, 1.18; 95% CI, 1.02-1.37), modified Elixhauser comorbidity score ≥ 3 (aOR, 1.38; 95% CI, 1.18-1.61), chronic pain syndrome (aOR, 1.41; 95% CI, 1.11-1.78), younger (18-64 years) age (aOR, 1.64; 95% CI, 1.34-2.00), need for percutaneous endoscopic gastrostomy/jejunostomy tube (aOR, 2.06; 95% CI, 1.21-3.52), and need for total parenteral nutrition (aOR, 1.70; 95% CI, 1.24-2.35) were associated with increased risk of 30-day readmission.

Conclusion: s One in 5 patients was readmitted with gastroparesis within 30 days. In the diabetic group, diabetes-related complications contributed to readmissions than gastroparesis. Pyloroplasty is associated with reduced early hospital readmission. Prospective studies are needed for validation of these results.

Keywords: Diabetes; Diabetes mellitus; Gastroparesis; Patients readmission.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None.

Figures

Figure 1
Figure 1
Study schematic and patient flow. NRD, Nationwide Readmission Database.
Figure 2
Figure 2
Predictors for early admission, multivariable analysis. GI, gastrointestinal; TPN, total parenteral nutrition; PEG, percutaneous endoscopic gastrostomy; PEJ, percutaneous endoscopic jejunostomy.

Similar articles

Cited by

References

    1. Parkman HP, Hasler WL, Fisher RS, American Gastroenterological A. American gastroenterological association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1589–1591. doi: 10.1053/j.gastro.2004.09.054. - DOI - PubMed
    1. Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108:18–37. doi: 10.1038/ajg.2012.373. - DOI - PMC - PubMed
    1. Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum RW. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998;43:2398–2404. doi: 10.1023/A:1026665728213. - DOI - PubMed
    1. Cutts TF, Luo J, Starkebaum W, Rashed H, Abell TL. Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits? Neurogastroenterol Motil. 2005;17:35–43. doi: 10.1111/j.1365-2982.2004.00609.x. - DOI - PubMed
    1. Nusrat S, Bielefeldt K. Gastroparesis on the rise: incidence vs awareness? Neurogastroenterol Motil. 2013;25:16–22. doi: 10.1111/j.1365-2982.2012.02002.x. - DOI - PubMed

LinkOut - more resources